(Q33337244)

English

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors (English)

1 reference

Europe PubMed Central

25 July 2017

gastroesophageal reflux disease

0 references

George Triadafilopoulos

2

object named as

George Triadafilopoulos

0 references

author name string

Lauren B Gerson

1

1 reference

Europe PubMed Central

25 July 2017

Peyman Sahbaie

3

1 reference

Europe PubMed Central

25 July 2017

Winston Young

4

1 reference

Europe PubMed Central

25 July 2017

Sheldon Sloan

5

1 reference

Europe PubMed Central

25 July 2017

Malcolm Robinson

6

1 reference

Europe PubMed Central

25 July 2017

Philip B Miner

7

1 reference

Europe PubMed Central

25 July 2017

Jerry D Gardner

8

1 reference

Europe PubMed Central

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 May 2008

1 reference

Europe PubMed Central

25 July 2017

BMC Gastroenterology

1 reference

Europe PubMed Central

25 July 2017

8

1 reference

Europe PubMed Central

25 July 2017

15

1 reference

Europe PubMed Central

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

23 May 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1471-230x-8-15

0 references

The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Rolling review: gastro-oesophageal reflux disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Measuring the accuracy of diagnostic systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Primer on certain elements of medical decision making

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

21 June 2018

Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Acid inhibition in GERD-how much is enough?

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Integrated acidity and rabeprazole pharmacology

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-15

21 January 2018

Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409349

31 October 2018

Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which pH threshold is best in esophageal pH monitoring?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18498663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-8-15

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33337244&oldid=1995040567"